FDA Investigates Fungal Infection Associated with Tennessee Compounding Pharmacy

The U.S. Food and Drug Administration, Centers for Disease Control and Prevention and Tennessee Board of Pharmacy are investigating seven adverse events reported from steroid injections compounded by Main Street Family Pharmacy in Newbern, Tenn.

All reported patients received 80 mg injections of preservative-free methylprednisolone acetate, and at least one injection appears to be fungal.

The FDA recommends all healthcare providers refrain from administering any Main Street sterile products and quarantining them until further notice.

More Articles on Anesthesia:
Survey: Pulse Oximetry Sensor Oxygen Reading Troubles Plague 53% Anesthesiologists
ASA Supports Congress in Expanding HIT Hardship Exemptions for Anesthesiologists
WPAH Names Dr. Ahmed Badr as Chair of Anesthesiology

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars